This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bubble Bursting? Only for Biotech & Internet Stocks

By Russ Koesterich, CFA, Chief Investment Strategist for BlackRock and iShares Chief Global Investment Strategist


Despite signs that most of the U.S. economic softness of the last three months was weather related, equities have struggled to push higher lately. The recent sluggish performance of U.S. stocks, especially those in the biotechnology and technology industries, is leading some market watchers to question whether we're witnessing the bursting of an equity bubble.

My take: I don't believe that U.S. equities overall are in a bubble. Though stocks certainly are no longer cheap, valuations are still a long way off from the late 1990s or the run-up to the 1987 stock market crash. That said, valuations certainly have started to become an issue, particularly for certain segments of the market.

For instance, at more than 25x current earnings estimates, valuations for small caps look outright expensive. And particular pockets of the market - like last year's growth stocks-are verging, or have already tipped into, bubble territory. The average price-to-book ratio for the Nasdaq Biotechnology Index is more than 7. As for Internet stocks, we are back to a world reminiscent of the late 1990s, where only the most creative metrics can justify the premiums being paid for certain companies.

Does all this suggest that the market has peaked and stocks are likely to come crashing down? Not necessarily. It's important to note that not all stocks look expensive. In the United States, the energy, healthcare, and surprisingly technology (not every tech stock is trading like Facebook) sectors are all trading comfortably below their historic valuations. Outside of the United States, stocks in Europe, Japan, and most of developed Asia range from reasonably priced to cheap.

In addition, while the market is certainly vulnerable to a spike in interest rates or an economy slowing more than expected, I don't expect these scenarios to occur. Rather, given my expectations of modestly accelerating economic growth and continued low rates in 2014, I still believe that the U.S. market will push ahead this year.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $124.15 0.62%
FB $83.65 0.88%
GOOG $552.53 -1.10%
TSLA $187.30 -3.60%
YHOO $45.50 2.90%

Markets

DOW 17,664.48 -13.75 -0.08%
S&P 500 2,055.95 -0.20 -0.01%
NASDAQ 4,865.5530 +2.1910 0.05%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs